APO-MOMETASONE
APO-MOMETASONE
Approved
DIN Number
02403587
Drug Class
Human
Market Date
Mar 25, 2013
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02403587
AIG Number0121732002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD09 MOMETASONE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MOMETASONE FUROATEActive
Strength: 50 MCG / ACT
Monograph: MOMETASONE FUROATE